Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants by Russell, PS et al.
KIDNEY  TRANSPLANTS  IN  MICE 
An Analysis of the Immune Status of Mice Bearing Long-Term, H-2 
Incompatible Transplants* 
BY  PAUL  S.  RUSSELL,  CATHARINE  M.  CHASE,  ROBERT  B.  COLVIN,  AND JANET  M.  D. 
PLATE 
(From the Transplantation Unit of the Surgical Services,  and the Departments  of Surgery and 
Pathology of the Harvard Medical School at the Massachusetts  General Hospital,  Boston, 
Massachusetts  02114) 
Transplants  of living organs among mammals  of the same species which 
differ  genetically  at the major histocompatibility  complex are usually rejected 
quite promptly.  There  are, however,  some  exceptions to this which  offer 
interesting opportunities for further study. The survival of liver  transplants 
among certain  pigs  which will  regularly  reject  skin grafts  or  kidney transplants 
from the same donors (1)  is  probably such  an exception,  but  the  lack  of  definition 
of  histocompatibility  relationships  in this  species  limits  detailed  studies  of  the 
immunological mechanisms involved.  Kidney transplants survive  longer than 
skin grafts  in some combinations of  inbred rats,  especially  when their  survival 
has been enhanced by the infusion  of an antiserum specifically  reactive  with 
donor antigens (2-4).  In the mouse, however,:  characterization  of  the immuno- 
genetics  of  histocompatibility  has been carried  further  than in other species  so 
that special  opportunities  are offered  for experiments in this  species. 
This report  describes  in detail  the experimental system of  kidney transplan- 
tation in the mouse. In preliminary communications we have reported that 
kidneys transplanted among mice involving  varying degrees of  histoincompatio 
bility  will  regularly survive longer than skin grafts  among the same strains 
with survival in good functioning order extending to many months in several 
strain  combinations (5,  6).  Transplant survival  does not depend upon exogenous 
immune alterations  of  any kind. Prompt rejection  of  kidney transplants  in mice 
can occur,  however, if  a sufficient  immunogenetic disparity  between donor and 
recipient  is present.  This is the case,  for example, when C57BL/6 kidneys are 
transplanted to (C3H × DBA/2)FI recipients  in which multiple incompatibili- 
ties  determined by  H-2 and non-H-2 complex genes exist.  This paper will  also 
describe the current status of our efforts,  especially  in one particular strain 
combination, to  elucidate  the immune relationship  between long-term function- 
ing kidney transplants  and their  apparently healthy,  H-2 incompatible, recipi- 
ents. 
Materials and Methods 
Animals.  Except  where specified  otherwise,  male mice were used throughout  as both donors 
and recipients.  This selection  was made because restoration  of urinary  drainage with our 
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technique is simpler in males. In most experiments, recipients were (C57BL/6J ×  A/J)F1 hybrids, 
hereafter referred to as B6AF~, while donors were of the B10.D2N strain, referred to as B10.D2. 
Hybrid recipients were selected for greater size and vigor. The B10.D2 donor and B6AF1 recipient 
combination constitutes a  situation in which the genetic differences are specified at the K  end of 
the 1-1-2 region. 
In some experiments A.SW strain mice were employed as cell or tissue donors. These animals 
present several antigens to B6AF1 recipients, including at least two private 1-1-2 specificities (H- 
2.12,19),  which are  not present on B10.D2  cells so that they are  a  suitable source of cells for 
ascertaining the responsiveness of B6AF~  mice to foreign histeeompatibility antigens other than 
those  presented  by  B10.D2  donors.  B10.BR  mice  were  also  used  in  some  specificity  control 
experiments.  Cells from this strain present weaker antigenic differences to the recipient strain 
which are determined at the D  end of the 1"1-2 region, including H-2.32.  Finally, some donors of 
the  C56BL/6  mutant  strain  B6.C-H(zl),  abbreviated  as  H(zl)  (7),  were  employed  in  kidney 
transplantation to B6AF~ recipients. This donor strain was of interest as it has been reported by 
others (8) and confirmed in our laboratory (P. Sugarbaker and H. J. Winn, personal communica- 
tion) that prompt rejection of skin grafts and active stimulation of recipient strain lymph node 
cells  by  donor  cells  in  mixed  lymphocyte  culture  (MLC)  occurs  with  the  incompatibilities 
represented  in  this  combination.  Nevertheless,  no  evidence  of  detectable  humoral  antibody 
production to donor cells, even after repeated stimulation in vivo, has been demonstrated. 
Operative Procedures on Mice 
SKIN  GRAftING.  Full  thickness  skin  grafts  were  performed  according  to  the  method  of 
Billingham and Medawar (9). Median survival times (MST)  ~ of skin grafts were calculated, where 
feasible, by the method of Litchfield (10)  and statistical comparisons were made by Student's t 
test. 
KIDNEY TRANSPLANTATION.  Donor and recipient mice weighing from 25 to 30 g were anesthe- 
tized with chloral hydrate (0.1 ml of a  3.6% solution per 10 g of body weight). The left kidney of 
the donor was mobilized with the ureter and bladder (Fig.  1). 
In the  recipient the  left renal  artery  and vein were  ligated together,  and the kidney  was 
removed. After ligation of appropriate lumbar branches, ties were placed around the aorta and 
vena  cava  together  caudad  and  individually  cephalad  to  the  intended  site  for  the  vascular 
anastomoses.  After occlusion of the aorta and vena cava by tightening the loops,  longitudinal 
openings were made in each. 
The donor was infused systematically with 0.5 ml of a chilled balanced salt solution containing 
7.5% heparin sulfate (7,500 U.S.P.  U  in 100  ml lactated Ringer's solution) into the vena cava. 
Aortic  arterial  inflow  to  the  kidney  was  occluded  and  the  donor  tissue  mass  was  removed 
including segments of aorta, vena cava, and the ureter with the dome of the bladder. End to side 
vascular anastomoses were constructed employing a continuous 10-0 nylon suture (Ethicon, Inc., 
Somerville, N.J.). The previously placed ties were removed allowing blood flow to the transplant. 
These maneuvers were facilitated by use of a dissecting microscope at varying magnifications for 
different portions of the procedure. Renal ischemia time was held to less than 35 rain. 
The  donor ureter  was  next  passed  under  the  left vas deferens to  reduce  the  chance of its 
kinking and the domes of the donor and recipient bladders were tailored to fit. The anastomosis of 
the two opened bladders was accomplished by using 9-0 nylon suture (Ethicon) in running fashion. 
The  right  kidney  was  then  removed.  Although the  operation  could  be  completed  in  98%  of 
recipients, 20-30% of animals failed to survive through the 3-day period immediately thereafter. 
These deaths were ascribed to the effects of operative trauma and animals were admitted to the 
various experiments only if they survived for 3 days after transplantation. 
The status of the transplanted kidney was evaluated by several means: the continuing survival 
of the recipient, serial blood urea nitrogen levels (BUN) by using a  standard colorimetric urease 
micromethod which requires about 0.02 ml of serum (blood samples being drawn from the retro- 
orbital plexus),  and by  microscopic  examination of sections of selected transplants.  Technical 
restrictions did not permit serial biopsy of an individual kidney transplant. 
KIDNEY SLICE IMPLANTATION.  In some  experiments  multiple slices of renal tissue,  each no 
1 Abbreviations  used in this paper:  BUN, blood urea nitrogen; Con A, concanavalin A; KTxS, 
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FIG.  1.  Diagram of the technique used for kidney transplantation in the mouse. Note that 
generous portions of donor aorta and vena cava are removed as part of the donor tissue 
specimen. A similar approach is taken to the restoration of urinary drainage with a  large 
patch of donor bladder. In male recipients the ureter is passed behind the vas deferens (as 
shown) to avoid kinking (see text). 
thicker than about 0.5 ram, were implanted as free grafts into clefts prepared in the hamstring 
muscles of recipients. In previous experiments with endocrine tissues we have found this to be a 
satisfactory recipient site for tissue implants of this thickness (11). 
SPLENECTOMY.  Splenectomy was performed through a subcostal incision with chloral hydrate 
anesthesia, as described above, and standard surgical technique. 
Graft Versus Host Assay.  As one method of assessing the immunological capacity of recipient 
lymphoid  cells,  the cells  to  be tested  were  injected  intravenously into  neonatal  B10.D2  mice 
within 12 h  of birth. The weights of these animals were recorded every other day thereafter and 
compared to those of uninjected controls reserved in each litter. We have found this "weight gain 
assay" to be a useful system for demonstrating the immunological competence of murine cells in 
vivo by  their capacity  to  mount  a  graft versus  host response which is  manifested by growth 
retardation and death of injected mice (12). 
Tumor Neutralization  Tests.  As a further test of the immunological capacity of recipient cells 
to respond to donor antigens in vivo their ability to inhibit the growth of a  tumor of donor tl-2 
genotype was evaluated. For this purpose the DBA/2 mastocytoma PS15-X2 was employed. Lymph 
node and spleen cells from various sources were mixed in appropriate ratios with one another and 
then  with  tumor  cells  before  injection  subcutaneously  into  B6AFI  female  recipients.  The 
dimensions of the resultant tumors were recorded daily thereafter and were interpreted according 
to the original description by Winn of the "tumor neutralization test" (13).  Ongoing estimates of 
tumor size were expressed as the average of the greatest and least diameters of a  tumor. 
In Vitro Studies of  Lymphoid Cell Responses.  Several in vitro assays of the immune responses 
of lymphoid cells were employed. 
MIXED LYMPHOID CELL CULTURES (MLC).  Mouse lymphoid cell suspensions were cultured in 
RPMI-1640 medium  (Grand Island Biological Co.,  Grand Island, N.Y.)  containing 5 mM Hepes 1452  AN  ANALYSIS  OF  KIDNEY  TRANSPLANTS  IN  MICE 
buffer (Aldrich Chemical Co.,  Inc., Milwaukee,  Wis.), 6% human serum,  100 U  of penicillin G, 
150  /~g of L-arginine,  2  mM  L-glutamine,  and 75  ~g of kanamycin sulfate/ml for 5  days.  Cell 
suspensions were transferred to 12  ×  75-ram disposable glass tubes and incubated at 37°C  in a 
humidified atmosphere containing 5% CO~. 'tOne-way" cell proliferation was achieved by use of 
irradiation to block cell division in one of the cell populations. These cells were submitted to 1,000 
rads from a  13~Cs source at a rate of 950 rads/min. Approximately 18-19 h before the cell cultures 
were harvested, a  pulse of 0.5 ~Ci of [3H]thymidine/ml was added (sp act 6.0 Ci/mmol; Schwarz/ 
Mann Div.,  Becton,  Dickinson &  Co.,  Orangeburg,  N.Y.).  The harvesting procedure has been 
reported previously (14). 
51CR RELEASE ASSAY.  The P815-X2 tumor was utilized as the slCr-labeled target (Na251CrO4; sp 
act,  1.0 Ci/ml; New England Nuclear Corp.,  Boston,  Mass.) to determine the presence of killer 
cells directed specifically against H-2K d antigenic determinants as is appropriate in the combi- 
nation of strains mainly employed in these experiments (B10.D2 to B6AFI). Concanavalin A (Con 
A) activated lymph node cells from A.SW mice served as targets to evaluate the specificity of 
killer cell induction. Blast cells recovered after a  48-72-hour incubation with 5  ~g of Con A/ml 
were labeled in 0.5 ml phosphate-buffered saline with 100 ~Ci s~Cr for 1 h  at 37°C.  The cells were 
then washed three times before use. 
The assay as described by Brunner et al., was modified slightly (14).  1 ml each of ~Cr-labeled 
target cells (2-5 ×  104/ml) and of lymphoid cells were mixed and centrifuged at 225g for 5 rain. At 
the end of the culture period the cells were briefly resuspended and centrifuged at 900 g  for 10 
min. The percentage of ~lCr released into the respective supernatant solutions was determined by 
dividing the specific experimental value of radioactive counts by the total amount of radioactivity 
detected in both the supernatant fluid and pellet of 51Cr-labeled target cells cultured alone. 
ASSESSMENT OF THE  GENERATION OF KILLER CELLS IN VITRO.  1 ml each of allogeneic irradiated 
and nonirradiated cells, 2.0 x  108 cells/ml, were mixed and incubated together for 5 days. At least 
10  tubes  of each  combination were  cultured  to  obtain  a  sufficient cell  yield  so  that  various 
dilutions of viable recovered cells could be mixed with s~Cr-labeled P815-X2 target cells in the 
chromium release assay (see above). 
ASSESSMENT OF SERUM-MEDIATED INHIBITION OF CELLULAR  RESPONSES IN VITRO.  Recipient strain 
lymph  node  cells  were  incubated in  a  1:4  dilution  of either  normal  mouse  serum  or  kidney 
recipient serum (KTxS). The cells were suspended at a concentration of 15 ×  106/ml of the diluted 
serum.  After a  30-rain incubation in a  37°C H~O bath, the cells were counted, resuspended, and 
cultured at a  concentration of 2  ×  106/ml with an equal number of irradiated donor strain cells. 
After 5 days in culture, the cytolytic activity of the cells was determined in a  s~Cr release assay. 
In control experiments an antiserum against H-2K  d antigens was employed.  This was collected 
from normal B6AF; mice which had been repeatedly injected with B10.D2 spleen and lymph node 
cells. It had a complement-dependent cytotoxic titer of 1:512. 
Assessment of Humoral Response to Sheep Erythrocytes (SRBC).  Mice received intravenous 
injections of 0.1  ml of a  2%  suspension of SRBC  in saline on days 0  and 7.  Blood was drawn 
repeatedly from individual animals to determine hemagglutination and hemolysin levels in the 
plasma. The techniques used in these assays were those described by Silver et al.  (15). 
Histology.  Tissue specimens were fixed by immersion in 10% neutral formalin in 50% ethanol, 
cleared in butanol, cut at 4  ~m after embedding in paraffin, and stained with hematoxylin and 
eosin. 
Cytotoxic Antibody to Cells.  Cytotexic antibody levels were determined in vitro against donor 
strain spleen or lymph node cells in a  two stage test.  Rabbit serum was used as the source of 
complement and trypan blue dye exclusion as the criterion of cell viability as described previously 
(16). 
Results 
Renal Isotransplants.  Bilateral  nephrectomy  and renal isotransplantation 
from B6AF1 donors was performed in 10 B6AF1 mice. Three animals died on the 
2nd  day  and  were therefore  not  considered further  in the  study.  One  of the 
remaining seven recipients still survives at 876 days (Fig. 2).  One animal died 
on day 51 and five were sacrificed on days 48, 499,  512,  516, and 656 days.  The P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVIN,  AND  J.  M.  D.  PLATE  1453 
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FIG. 2.  The survival of renal isotransplants (B6AFI to B6AFI) is compared to that of 
allotransplants from B10.D2 donors to normal B6AFI recipients  or to B6AF~ recipients 
which have been previously immunized to B10.D2 cells  (see  text).  The number of  animals 
in each group is indicated. Only those recipients  which survived for at least  3 days are 
included in these data.  About 30% of  the transplants to normal recipients  fail  during the 
1st mo after  transplantation. Very few are lost  thereafter.  A  much higher percentage of 
transplants to preimmunized recipients  is  destroyed early. 
BUN levels of the  seven  survivors,  measured  between 30  and  45  days  after 
transplantation,  were 20, 22, 23, 24, 26, 27, and 40 mg/100 ml (average 26.0 mg/ 
100 ml). On examination of sections of fixed tissue from these transplants little 
evidence of inflammation was seen and signs of significant ureteral obstruction 
were generally minimal. 
In  other  control  experiments  it  was  found  that  eight  animals  undergoing 
unilateral  nephrectomy survived indefinitely,  maintaining  BUN levels in the 
normal range,  i.e.,  15-30 mg/100 ml with an average of 22.4 mg/100 ml. 
Bilaterally  nephrectomized  B6AFI  mice  succumbed to  uremia  within  36  h 
with BUN levels from 80 to 200 mg/100 ml. 
Survival of Allogeneic  Kidney Tissue  Transferred  to Normal Recipients 
KIDNEY  TRANSPLANTS  TO  NORMAL  RECIPIENTS.  B10.D2 kidneys  were  trans- 
planted  to normal B6AF1 male mice and the course of the animals was followed. 
The pattern of survival of these animals is depicted graphically in Fig. 2. Since 1454  AN  ANALYSIS  OF  KIDNEY  TRANSPLANTS  IN  MICE 
FIG. 3.  Histological  changes observed in B10.D2 kidneys transplanted to B6AFI recipi- 
ents.  (A)  Allotransplant removed at  9 days after  transplantation.  An intense mononuclear 
infiltrate  is  present and is  associated  with  tubular damage and  margination along  arterial 
endothelium.  This and other sections  are stained with hematoxylin and eosin (no.  338, x 
190).  (B)  Allotransplant removed at  56  days after  transplantation.  No infiltrate  is  present 
and  the  tubules appear normal. The top glomerulus has a segmental scar (no.  697, x 190). 
(C) Allotransplant removed  at 71 days after  transplantation. This large artery shows 
marked intimal  proliferation  and  infiltration  by  mononuclear cells.  Only  a  scant  interstitial 
infiltrate  is  present in  the  cortex  and the smaller arteries  are normal (no.  687, x 300). 
early survival of kidney isotransplants exceeds that of allotransplants,  the loss 
of about 30% of the allotransplants  in the 1st mo must be attributable mainly 
to  rejection.  By  following  the  course  of 92  recipients  of allografts,  it  was 
apparent that deaths became much less common after the 1st mo. Late kidney 
failure  may,  of course,  be  due  to  the  cumulative  consequences  of technical 
factors  as well as rejection activity.  During  the 70-day period from  30 to  100 
days postoperatively, the additional loss of animals with gradually  advancing 
uremia was about 20%. Several recipients have survived for as long as 1 yr with 
normal  renal  function.  Mice  that  survive  longer  than  this  tend  to  have  a 
gradual rise in their BUN levels. 
Early rejection is characterized  by intense  mononuclear  infiltration.  Mono- 
nuclear cells invade tubules,  accumulate  along the arterial  endothelium,  and 
may mediate tissue damage at these sites (Fig.  3A). An adaptive phase occurs 
subsequently as time progresses.  Samples taken  during  this  period showed a 
remarkable regression of the interstitial  infiltrate  and little  or no evidence of 
residual tubular damage  (Fig.  3B).  A  late phase follows in which some tissue P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVlN,  AND  J.  M.  D.  PLATE  1455 
damage,  especially to arterial  vessels and  giomeruli,  gradually  appears.  The 
changes consist of some mononuclear cell infiltration  and intimal proliferation 
beginning  in larger  renal  arteries  (Fig.  3C).  Similar  lesions  are  well known 
features of human renal allografts (17). Glomerular damage seems to be slowly 
progressive over the duration of survival of the allografts. The mechanisms for 
these late changes have not yet been established. 
Seven  B10.D2  kidneys  from  female  donors  were  transplanted  into  female 
B6AF1 recipients to explore the possibility of a  difference in responsiveness of 
female recipients  to transplanted  kidneys in this  strain  combination.  Five of 
these  survived  in  excellent  condition  for  over  4  wk,  thus  demonstrating  no 
detectable difference attributable to the sex of the recipient. 
12 H(zl) kidneys transplanted  to B6AF1 recipients were studied.  Of these, 9 
survived beyond 3 days in excellent condition with BUN levels ranging from 19 
to 36 mg/100 ml for at least 5 wk. Accordingly, their survival was quite similar 
to that seen for B10.D2 kidneys to B6AF1 recipients. 
KIDNEY IMPLANTS.  Two to four B10.D2 renal slices comprising, in aggregate, 
at least one third  of a  kidney were implanted  bilaterally into the hamstring 
muscles of each of 12 adult male B6AF1 recipients. Donor kidneys were perfused 
exactly as for transplantation  before preparing  the  tissue  slices to eliminate 
any variation in number of'~passenger leukocytes." In selected cases blocks of 
muscle tissue containing the implants were excised 11-14 days after grafting for 
histological  examination.  By this  time  the  normal  renal  architecture  of the 
implants  was  scarcely  recognizable  as  it  was  largely  effaced  by  a  dense, 
mononuclear cell infiltrate which was considered to be entirely characteristic of 
allograft rejection. Donor strain skin grafts were applied later to some of these 
recipients  (see below). 
Kidney  Transplants  to Preimmunized Recipients.  Five male  B6AF1 mice, 
which  had  received  and  rejected  B10.D2  skin  grafts,  underwent  bilateral 
nephrectomy and transplantation  of B10.D2 kidneys from 1 to 14 days after skin 
graft rejection was complete.  Their  survival is shown in  Fig.  2.  Early loss of 
transplants  was much greater in this group.  Indeed, over half were unable to 
support the life of their recipients for more than 5 days. Nevertheless,  it is of 
interest that one animal survived for a prolonged period (122 days) before being 
sacrificed. 
Kidney  Transplants  to  Splenectomized  Recipients.  B10.D2  kidneys  were 
transplanted to nine recipients which had undergone splenectomy from 12 to 27 
days previously.  Several reports have appeared  (18-20) that  splenectomy of a 
recipient impairs active immunological enhancement  of transplants,  although 
this  is not agreed to by all authors  (21).  Accordingly,  it was noteworthy that 
five of these kidney transplants survived in excellent condition for many weeks, 
thus  demonstrating  no  influence  of prior  splenectomy  on  renal  transplant 
survival in this group of animals. 
Survival of Test Skin Grafts to Kidney Recipients.  15 B6AF~ recipients were 
selected which had born B10.D2 kidney transplants  for 40-60 days. Skin grafts 
from  B10.D2  donors  to  these  recipients  survived  as  recorded  in  Fig.  4.  The 
presence of a  surviving kidney transplant  greatly extended the life of a  later 
skin graft from the donor strain with over 65% of grafts surviving for more than 
1 mo. Beyond this period many grafts gradually lose their hair,  shrink in area, 1456  AN  ANALYSIS  OF  KIDNEY  TRANSPLANTS  IN  MICE 
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FIG. 4.  The survival  times  of  donor  strain  (B10.D2) skin grafts  to  normal B6AF~ recipients 
or to recipients  of  previous grafts  of  B10.D2 kidney tissue.  Kidney tissue  was transferred 
either  by  transplantation or  in  free  implants of  renal slices  to  the  leg  muscles. The number 
of animals in each group is indicated. Transplant recipients, which are healthy and 
maintaining BUN  levels  in the normal range, support the prolonged survival of donor 
strain  skin grafts  whereas recipients  of  kidney tissue  implants reject  grafts  in accelerated 
fashion.  This alteration  is  specific  for  the donor strain (see  text). 
and are slowly rejected in succeeding weeks. In several instances, however, the 
grafts remained in excellent condition for well over 1 yr. In no case was there 
any evidence that the presence of the skin graft influenced the function of the 
kidney transplant.  This  behavior  of skin  grafts  differed  markedly  from that 
observed with normal B6AF1 recipients  (MST 13.5  _+  1.1 days). 
That  this  alteration  in  recipient  responsiveness  was  particularly  evident 
toward the donor strain is shown by the fact that skin grafts from A.SW donors 
to  nine  B6AF1  kidney  transplant  recipients  during  the  same  period  after 
transplantation  were rejected with an MST of 10.2  _+  1.03 days (MST of A.SW 
skin grafts to normal B6AF1 recipients is 10.5  +_ 1.1 days). Another test of the 
specificity of immunological reactivity of kidney transplant recipients consisted 
of measuring their responses to SRBC. Four B6AF~ recipients of B10. D2 kidney 
transplants which were in good condition from 13 to 166 days after transplanta- 
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responses of eight normal controls,  were unimpaired.  For example, at 21 days 
after  SRBC,  the  transplant  recipients  showed  hemaggiutinin  titers  ranging 
from 160 to 640 which is the same range as that found in normal animals.  This 
is further evidence that transplant  recipients are capable of mounting normal 
immune responses to antigens not present in the donor tissue. 
Of interest  was the additional  finding that  B10.D2 skin grafts to 10 B6AF1 
mice  about  4  wk  after  receiving  B10.D2  kidney  implants  were  rejected  in 
accelerated  fashion  (MST  9.1  ___  1.02  days,  Fig.  4).  Accordingly,  a  striking 
difference  in  immune  responsiveness  to  donor  antigens  occurred  depending 
upon whether  the  donor kidney tissue  was implanted  as a  free graft  or was 
transplanted  with primary vascular union. 
Analysis of  Immune Responsiveness of  Kidney Transplant Recipient Lymph- 
oid  Cells.  Several  tests  of the  immune  responsiveness  of lymph  node  and 
spleen cells from B6AF1 recipients bearing B10.D2 kidney transplants for 1 mo 
or more were made, both in vivo and in vitro. 
In Vivo Tests 
CELL  TRANSFER  TO  NORMAL  ADULT  MICE.  Lymph node  cells from  11  long- 
term  B6AF1 recipients  of B10.D2  kidney  transplants  were  pooled and  trans- 
ferred i.p. to normal B6AF1 mice in a dosage of 2 x  l0  s cells per mouse. This cell 
dosage was selected  as  it had  been  shown by Kilshaw  et  al.  to demonstrate 
marked suppressor cell activity in mice in which specific unresponsiveness to 
allogeneic  skin  grafts  had  been  induced  by  treatment  with  donor  strain 
lymphoid  cells,  anti-lymphocyte  serum,  and Bordetella pertussis  (22).  Three 
animals were treated in this particular experiment with the prescribed number 
of cells. 2 days after receipt of the cells, B10.D2 skin grafts were placed on these 
animals.  These grafts  were rejected in 12,  14,  and  15 days  (MST  13.0  _+  1.03 
days). The MST of B10.D2 skin grafts to 4 B6AF~ mice which had received the 
same  number  of cells  from  mice  which  had  recently  received  and  rejected 
B10.D2 skin grafts was 10.0 _+ 1.02 days. These figures were compared also with 
the MST of B10.D2 skin grafts to normal  B6AF1 recipients of 13.5  ___ 1.1 days. 
All these skin grafts were performed at the same time as we have found that 
slight differences in skin graft survival can be observed from time to time even 
under seemingly standardized conditions. The survival of skin grafts to animals 
which  had  received  cells  from  kidney  transplant  recipients  did  not  differ 
statistically from the normal  MST (P >  0.05)  whereas significant acceleration 
of rejection was demonstrated after transfer of immunized  cells (P  <  0.01).  In 
other  experiments,  done  at  several  different  times,  pooled  lymph  node  and 
spleen cells from a  total of 17 kidney transplant  recipients were transferred to 
normal B6AF~ mice at the dosage mentioned above. No evidence of suppressor 
cell  activity  was  apparent  by  observing  skin  grafts  to  10  B6AF~  recipients 
treated in this way. 
Larger  numbers  of cells  were  not  employed  as  this  experimental  design 
required  an  uneconomical  use of cells  from the  necessarily small  number  of 
kidney transplant  recipients  available.  Further  tests for the presence  of sup- 
pressor cells accordingly made use of other types of cell transfer systems and of 
in vitro tests in which fewer cells could be employed (see below). 
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FIG.  5.  The capacity of pooled spleen and lymph node cells to produce a graft versus host 
reaction (GVHR) (runt disease) was determined by following the gain in body weight of 
neonatal B10.D2 mice injected intravenously with the cells to be tested. Each of several 
litters was divided into three groups, some receiving 107 viable spleen and lymph node cells 
from normal adult B6AF~ donors, some the same number of cells from B6AF~ recipients of 
B10.D2 kidneys, and some receiving no treatment. The mean weights of each group are 
plotted.  At the  cell dosage  tested,  no  difference is  detected by  this  test  between  the 
responsiveness of cells from normal and kidney transplant recipient animals. The number 
of animals entering each group is indicated, and the range of recorded weights is plotted at 
representative points. 
from  long-term  kidney  transplant  recipients  to  generate  a  specific  immune 
response to donor strain antigens in vivo was tested by delivering 1  x  107 pooled 
lymph node and spleen cells intravenously  to newborn  B10.D2 mice and observ- 
ing their gain in body weight thereafter.  The results from four separate litters 
were combined. In each litter some neonatal  mice received normal  B6AF1 cells, 
some received kidney transplant  recipient cells and some were left uninjected. 
As Fig. 5  shows,  these cells were fully capable of mounting  a  graft-versus-host P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVIN,  AND  J.  M.  D.  PLATE  1459 
response in neonatal hosts as they produced a retardation in growth which was 
indistinguishable from that after the injection of the same number of cells from 
normal adult B6AF1 mice. Littermate controls which were uninjected developed 
at the normal rate. 
CELL  RESPONSIVENESS  AS  EVALUATED  BY  THE  e~TUMOR NEUTRALIZATION 
TEST."  For these experiments the target employed was the P815-X2 mastocy- 
toma.  5,000,000  viable  tumor  cells  injected  subcutaneously into  each  B6AFI 
recipient  produced a  tumor  mass which reached  a  size of about  7-10  mm  in 
greatest diameter by 6-8 days before the tumor cells were gradually rejected by 
the active immune responses of the host. When this number of tumor cells was 
mixed  with  an  equal  number  of pooled  lymph  node  and  spleen  cells  from 
preimmunized  B6AF~ mice, the combined inoculum of tumor cells and immu- 
nized  lymphoid cells resulted  in  a  barely palpable  growth.  Lymph node  and 
spleen  cells from kidney transplant  recipients  mixed  in  equal  numbers  with 
tumor cells had no detectable influence on tumor growth in normal B6AF~ mice. 
A  main objective in using this system was to determine whether cells from 
kidney transplant  recipients would suppress the action of preimmunized  cells 
on the  tumor  in  vivo as compared  to  normal  recipient  strain  cells.  In  these 
experiments  inhibition  of growth of the tumor caused by an equal number of 
sensitized cells was reduced after the addition of a like number of either normal 
or kidney transplant  recipient  cells,  but kidney transplant  recipient  cells did 
not have  a  greater  influence  in this  regard.  Indeed,  it  seems likely that  the 
effect of secondarily added cells from either of these sources was simply to dilute 
the impact of the sensitized cells on the tumor. 
In summary, these experiments yielded no evidence that cells from long-term 
kidney  transplant  recipients  can  suppress  the  specific  immune  reactivity  of 
previously immunized lymphoid cells against donor antigens in vivo under the 
conditions employed. 
In Vitro Tests 
CELL-MEDIATED CYTOTOXICITY.  Spleen cells from 16 kidney transplant recip- 
ients were evaluated individually to determine whether immune cytotoxic killer 
cells could be detected at times ranging from 42 to 372 days after transplanta- 
tion.  The  average  quantity  of 5~Cr released from labeled target  cells  did not 
differ significantly  (P  >  0.05) from that  produced in cultures  with cells from 
normal B6AF~ mice. Assays were performed under various conditions including 
rocking versus stationary  cultures,  4,  6,  9,  or 16 h  of incubation,  and test to 
target cell ratios of 50:1,  100:1, or 200:1  (detailed data not shown).  Mice which 
had recently rejected B10.D2 skin grafts or had received a series of intraperito- 
neal injections of B10.D2 lymphoid cells yielded spleens which contained easily 
detectable killer cell activity. 
Experiments  in  which  test  cells  were  mixed  in  varying  proportions  with 
target  cells indicated that  few if any cytotoxic killer  cells are present  in the 
spleens of kidney transplant  recipients at 40 days or longer after transplanta- 
tion.  Similar  results  followed when lymph node cells were tested in this  way 
(Fig.  6). 
MIXED  LYMPHOCYTE CULTURES.  The  proliferative  responses  of  lymphoid 
cells from kidney transplant  recipients after stimulation with irradiated donor 146Q  AN  ANALYSIS OF  KIDNEY TRANSPLANTS IN  MICE 
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FIG. 6.  A comparison of the ability of lymphoid cells from kidney transplanted,  immune 
and  normal  animals  to cause killing  in vitro.  Specifically immune lymphoid cells were 
obtained from B6AF1 mice which had been grafted on two consecutive occasions with skin 
from B10.D2 donors (days 0 and 19), and which were then injected on day 29 with 7 × 107 
B10.D2 lymphoid cells. Spleens and lymph nodes were removed 4 days later and titrated for 
killer  cell activity  in  a  51Cr release  assay  against  P815-X2 tumor  cells. The  kidney 
transplant recipients  tested  had received B10.D2 kidneys 54, 56,  59,  and 63 days before 
removal of their spleens and lymph nodes (1.n.). Lymphoid cells from normal B6AF1 mice 
served as controls. Supernates from the assays were evaluated for 51Cr-release after an 8 h 
incubation. Spontaneous 51Cr-release was 19.8%. Active killer cells were not detected in the 
spleens of kidney  transplant  recipients  as compared to the killing  activity  of different 
numbers of specifically immune cells. 
strain cells were compared to the levels of response attained by normal recipient 
strain  cells.  The responses of three long-term survivors of kidney transplants 
(118-199 days) were similar to normal levels of response (Table I). 
GENERATION OF KILLER  CELLS.  Kidney transplant recipient spleen cells from 
these  same  mice  were  also  incubated  with  irradiated  donor  strain  cells  to 
determine  their  ability to  generate  cytotoxic effector cells.  While  significant 
cytolysis  was  detected  in  the  subsequent  CMC  assay,  the  levels  of killing 
attained were substantially lower than the levels of killer cell activity generated 
by cells from normal B6AF1 mice (Fig. 7). Further studies have confirmed these 
results in that nucleated splenic cells from five out of six mice bearing foreign 
kidney transplants for 118 days or longer produced lower levels of killer T cells 
than cells from normal mice. 
In another series of experiments,  spleen cells from kidney transplant recipi- 
ents were sensitized in vitro against irradiated B10.D2 and A.SW cells.  While 
only one out of five recipients yielded detectable levels of killer cells against the P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVIN,  AND  J.  M.  D.  PLATE 
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Responses  in MLC of KTxR and Normal B6AFz Cells 
1461 
Kidney transplant recipients*  Normal B6AFI 
Animal  Days  Cell source  Alone  +B10.D2  Cellsource  Alone 
no.  post Tx  (1,000  rads) 
cpm 
529  118  LN  1,677  53,145  LN  11,744 
Spleen  22,937  108,145  Spleen  25,195 
507  199  LN  3,028  113,216  LN  729 
535  134  LN  15,488  49,818  LN  2,737 
* B10.D2 into  B6AFI kidney transplants. 
+B10.D2 
(1,000  rads) 
cpm 
148,588 
97,149 
82,756 
37,606 
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FIG.  7.  The ability of B6AFI lymphoid cells from long-term recipients of B10.D2 kidney 
transplants to become sensitized in vitro. Nucleated splenic cells from transplant recipients 
and normal B6AF1 mice were cultured with irradiated donor strain cells (B10.D2)  at 2 × 10  e 
each/culture.  5  days  later  the  cultured  cells were  evaluated  in  a  51Cr-release  assay  to 
measure the level of sensitization that had developed. Spleen cells from kidney transplant 
recipients show reduced  sensitization to donor antigen by this test as compared  to cells 
from normal mice. 
donor strain H-2  d targets, five out of six developed significant levels of killer 
activity directed against the A.SW H-2  s target antigens (data not shown). This 
is further evidence that transplant recipients have specifically depressed abili- 
ties to generate killer cells against the antigens of the donor kidney.  • 
SUPPRESSOR  CELL ASSAYS.  Two  types  of tests  were  employed.  One  was 
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TABLE II 
Effect  of  Preincubated Kidney Transplant Recipient Cells  (KTxR) on Killing  Activity  of 
Immune Cells 
Preincubated  mixtures added to CMC  as- 
say* 
% Specific 5~Cr-release* 
Cell donors for CMC assay 
Nonimmune 
None  Immune B6AFI  B6AF1 
None  -  1.8  55.4 
Normal cells alone  0  1.2  56.0 
KTxR cells alone§  0  1.2  56.0 
Normal cells  + PSI5-X2  H 
KTxR cells  + P815-X2 
0  0.3  46.7 
0  0  44.0 
Normal cells + B10.D2 (1,000 rads)¶ 
KTxR cells + B10.D2 (1,000 rads) 
0  1.6  53.1 
0  1.6  50.9 
* Spontaneous release  =  33.0% after 17 h  CMC assay. 
Preincubated  at  37°C  for 23  h  and used in CMC  assay at a  ratio of 1:1  with nonimmune and 
immune B6AF1 cells. 
§ Pool of spleen cells from two kidney transplant recipients. 
II Normal and KTxR  cells preincubated with PS15-X2 at 100:1. 
¶ Normal and KTxR  cells preincubated with B10.D2 cells at 3.3:1. 
normal cells and the other to evaluate a suppressive effect on the expression of 
immunity by preimmunized cells. 
For the first test kidney recipient cells and normal B6AF1 cells were mixed at 
ratios of 1:6, 1:3, and 1:1 and were sensitized together in culture for 5 days by 
irradiated donor strain stimulating cells. No suppression of  the normal response 
was detectable at any ratio of kidney recipient cells to normal cells when these 
cultured cells were tested in a CMC assay. 
In the second test for suppression,  normal or kidney recipient spleen cells 
were incubated for 23 h with tumor target and irradiated donor strain cells. The 
effect of these preincubated cell mixtures on the capacity of immune cells to kill 
51Cr-labeled  tumor targets was assessed. No suppression of immune effector cell 
function was evident in any of the combinations (Table II). Similar procedures 
have been reported to reveal evidence of suppressor cells in NZB mice against 
syngeneic or autochthonous flbroblasts (23). The lower levels of 51Cr-release  in 
the  assays  with  mixtures  preincubated  with  P815-X2  tumor  cells  probably 
reflects  the  slight  inhibition  which  is  to  be  expected  from  competition by 
unlabeled target cells. No killer cells were generated by cells from either kidney 
transplant recipients or normal B6AF~ animals during the 23 h  of incubation 
with either irradiated B10.D2  cells or PS15-X2 tumor cells. 
These data indicate that kidney transplant recipients contain approximately 
normal numbers of lymphoid cells that proliferate in response to H-2 antigenic 
stimuli (helper T cells) but that long-term recipient mice are deficient in their 
functional prekiller T-cell  subpopulations.  Also,  despite the  presence  of the 
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would be expected for secondary responses indicating again that these recipients 
have few or no immune "memory" cells. 
Analysis of Serum from Kidney Transplant Recipients.  Serum was collected 
repeatedly from the retro-orbital sinus of 16 B6AF1 recipients of B10.D2 kidney 
transplants  at  times  ranging  from  30  to  300  days after transplantation.  The 
tests to be described were performed with  a  single  pool of serum  from these 
collections.  Complement-dependent  cytotoxic antibody  was  not  detectable by 
our technique  in this  serum  pool.  Individual  serum samples from transplant 
recipients,  however, were sometimes shown to contain cytotoxic antibody (see 
below). 
IN VIVO TESTS.  To test the capacity of this serum to enhance the survival of 
donor strain test skin grafts, a regimen for serum administration was employed 
which exceeded in dosage (volume) that previously shown in our laboratory to 
be effective in producing enhancement of skin grafts in this strain combination 
with several antisera which contained demonstrable cytotoxic activity (24).  10 
mice received 0.2 ml of serum i.p.  on days 0, 2, and 4 with respect to receiving 
B10.D2  skin  grafts.  The  MST  of these  grafts  was  14.0  _  1.1  days.  When 
compared to the MST of such grafts on untreated  recipients  (13.5  _+  1.1  days) 
the difference was not significant  (P >  .05). 
IN VITRO TESTS.  (a)  Cytotoxic antibody titers  were determined  repeatedly 
on  46  B6AF1  recipients  of B10.D2  kidneys.  The  percentage  of animals  with 
detectable antibody titers declined from 24% at 4 wk to 7% after 12 wk. Antibody 
titers also declined from an average of 1:64 at 4 wk to 1:4 after 12 wk. 
(b)  The recipient serum pool was tested to determine whether it could inhibit 
the cytolytic activity of immune T cells and/or the ability of normal B6AF1 cells 
to generate effector T cells during sensitization in vitro. 
Kidney recipient serum and normal mouse serum, each at a concentration of 
hl0,  were  added  to  tubes containing  decreasing  concentrations  of sensitized 
B6AF1 cells. ~lCr-labeled P815-X2 target cells were also added and the mixtures 
incubated  for  4.5  h  as  outlined  in  Materials  and  Methods.  No  inhibition  of 
killing  activity was effected by the  kidney recipients'  serum  (Table III).  The 
inability of this serum to block killing activity of sensitized cells is particularly 
evident at lower ratios of sensitized to tumor target cells. Antiserum raised in 
B6AF~ mice against B10.D2 skin and/or lymphoid tissues blocked killing in this 
assay completely (data not shown). 
The same kidney recipient serum pool could, however, suppress the genera- 
tion  of killer  cells in cultures  in which normal  B6AF~  cells were mixed with 
irradiated B10.D2 donor strain cells. Serum from long-term recipients of B10.BR 
strain kidneys also depressed the ability of B6AF~ cells to generate killer cells 
against  H-2K  ~ antigenic  targets  (see reference  6  for results  with  this  strain 
combination).  The  suppressive  effect  observed  with  the  kidney  recipients' 
serum, therefore, does not appear to be antigen specific. Its influence, however, 
is confined to a  limited '~phase" of the development of the immune response in 
that the serum does not suppress the activity of immune cells but depresses the 
ability of nonimmune cells to differentiate into effector cells. The nature of this 
suppressive substance offers an opportunity for further investigation. 1464  AN  ANALYSIS  OF  KIDNEY  TRANSPLANTS  IN  MICE 
TABLE  III 
Effect of Kidney Transplant  Recipient Serum on the Killing 
Activity of Immune Cells 
Type of serum 
% 5~Cr-release* 
Sensitized cells/Target cells 
20:1  10:1  5:1  2.5:1 
NMS  78.3  70.2  54.2  45.6 
KTxR Serum  76.9  71.5  61.6  46.0 
* Spontaneous  release  of 51Cr-labeled  PS15-X2  =  22.9%  after  a  4.5-h 
assay. 
S B6AF~  cells  were  sensitized  for  5  days  in  vitro  against  irradiated 
B10.D2 cells. 
Discussion 
These  experiments  have  demonstrated  that  transplant  rejection  in  several 
combinations  of mouse  strains  is  much  less  vigorous  against  kidneys  than 
against  skin grafts from the same donor strain.  That this difference does not 
depend upon antigens peculiar to skin was shown by the fact that slices of renal 
tissue,  implanted as free grafts,  were rejected at about the same rate as skin 
grafts.  The  recipients  of implants  of renal  tissue  are  specifically immunized 
after graft rejection. By contrast,  however, primarily vascularized renal trans- 
plants provoke a much weaker rejection response which tends to diminish with 
time.  This is suggested by the distinct clearing of infiltrating  leukocytes from 
transplanted kidneys after the first 3-4 wk and by the diminished prevalence of 
complement-dependent  cytotoxic antibody in the sera of transplant  recipients 
as time progressed. 
In  another  series  of experiments  employing  primarily  vascularized  heart 
transplants  between mice,  Corry et al.,  in our laboratory,  made some similar 
observations  with  B10.BR hearts  transplanted  to  B6AF1  recipients.  In  this 
strain combination, the transplanted hearts functioned well for about 3 wk but 
then entered a period during which the heart beat was greatly reduced before it 
was restored spontaneously to normal  (25).  In a  later study, Corry found that 
donor strain skin grafts were rejected in somewhat accelerated fashion in this 
strain  combination  if applied  soon  after heart  transplantation  but that  later 
skin  grafts  enjoyed  prolonged  survival  (26).  It  appears  that  although  heart 
transplants  have the capacity, under the right conditions, to induce an altera- 
tion in recipient immune responses, they are less able to do so than are kidney 
transplants.  This  is  certainly  the  case  in  the  strain  combination  we  have 
studied  most  intensively  (B10.D2  donors  and  B6AF1  recipients)  since  heart 
transplants are all promptly rejected in contrast to the long survival of kidneys 
transplanted  between these strains. 
The set of circumstances which evolves spontaneously in our animals may be 
similar  to that  obtaining  with long-surviving  kidney or heart  transplants  in 
some rats which can be produced by the treatment  of recipients with a  short 
course of injections of an antiserum directed against the foreign antigens of the 
donor.  Generally,  F~ transplants  to a parental  strain recipient are required for P.  S.  RUSSELL,  C.  M.  CHASE,  R.  B.  COLVIN,  AND  J.  M.  D.  PLATE  1465 
long-term survival. Evidence has been advanced, especially by Batchelor and 
his colleagues (27)  that these animals enter a "steady state"  which persists  long 
after  the originally infused antibody has disappeared. In our untreated recipi- 
ents it  is  unclear as  to  whether the antibody against donor cells  which was often 
detectable contributed to the development of  the steady state  which developed 
in them. It is probable that antibody at low levels is present throughout the 
survival of  the recipient.  Nevertheless, two facts  from our in vivo experiments 
make it  unlikely that antibody is indispensable to the suppression of  the early 
rejection reaction. First, the fact that prior splenectomy,  which  generally 
lessens the  vigor of active enhancement,  did  not curtail the  survival  of 
transplanted kidneys does not support the concept that conventionally defined 
enhancement  contributes to the onset of the "steady state" in our animals. 
Secondly, the fact  that kidneys from H(zl) donors survived in  the absence of  any 
detectable antibody to them is evidence in the same direction. 
The immune alteration in recipient responsiveness after  the transplantation 
of a kidney in the strain combinations  tested has a considerable  degree of 
specificity. Donor skin grafts (B10.D2)  often survived for many weeks whereas 
skin grafts presenting strong new antigens (A.SW) were rejected normally. The 
response  to  sheep  erythrocytes was  also  normal.  Nevertheless,  there  is  no 
justification for classifying this phenomenon as an example of actively acquired 
immunological tolerance as there is ample evidence that lymphoid cells from 
kidney transplant recipients can mount vigorous immune responses to donor 
antigens both in vivo and in vitro. Furthermore, no evidence could be found for 
the participation of suppressor cell activity by either in vivo or in vitro tests. 
Although  graft versus host assays established that cell populations from 
kidney recipients  were capable of  producing effective  immune responses in vivo 
which were indistinguishable from those generated by cells  from normal donors, 
the cell doses used were large and the discriminatory  capacity of the test 
employed was probably insufficient  to reveal reductions in immune responsive- 
ness of  the inoculum. In vitro  tests  offer  easy flexibility  in varying the numbers 
of  cells  in the reaction mixture and these provided evidence for a reduction in 
cellular responsiveness.  It must be remembered  that this balanced  system 
probably involves the continual turnover of  poSentially  reactive cells  which are 
constantly being influenced by their surroundings, and single  samplings of  the 
components of such a system may not reveal how the balance is maintained. 
Nevertheless,  it was considered  significant that long-term recipients, on re- 
peated testing,  showed a reduction in functional precursors of  killer  T cells  as 
well as showing no evidence for  the presence of  active  killer  T cells  themselves, 
whereas such cells  were readily produced on stimulation by antigens which had 
not been present in the transplanted kidney. This deficiency of  immune  cells 
and in pre-killer  cells  appears to be specific  in that relatively  normal levels  of 
killer  cells  could be induced against A.SW target cells.  The fact  that almost all 
transplanted kidneys were rejected promptly when transplanted to recipients 
which had previously been immunized by donor strain skin grafts shows that 
such rejection  is  possible and is  consistent with the notion that immune effector 
cell  generation is somehow insufficient  to produce decisive rejection  by normal 
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The nature and significance of the suppressive substance detected in recipient 
serum by in vitro tests have not been established. Further studies to define the 
mechanism of this  specific deficiency are  needed.  Meanwhile,  an  additional 
dimension of understanding of the immunological balance between the trans- 
planted organ and its surviving host has been gained by various approaches to 
upsetting this balance as reported in an accompanying paper (28). 
Summary 
Kidney transplants between strains of mice which are incompatible at either 
the K  or the D  end of the H-2  complex usually function for prolonged periods 
supporting the lives of nephrectomized recipients. This occurs with no recipient 
treatment. With multiple H-2 and non-H-2 determined incompatibilities, trans- 
plants  may  be  rejected  but  more  slowly  than  skin  grafts.  In  the  strain 
combination studied most extensively in these experiments (B10.D2  to B6AF1) 
in which the incompatibility was confined to the K end of the H-2 region, about 
70%  of recipients survived for many weeks with normal blood urea nitrogen 
levels. Skin grafts between untreated members of these strains were rejected 
promptly (mean survival time of 13.5 _+ 1.1 days) as were kidney transplants to 
recipients of prior skin grafts. Donor strain skin grafts to recipients of kidney 
transplants  after  kidney transplantation enjoyed greatly prolonged  survival 
whereas skin grafts from a third party (A.SW) were rejected normally. If kidney 
tissue  was  transferred in  the  form of free  grafts  without primary  vascular 
union, it was rejected promptly leaving its recipient highly immunized. 
Cellular and humoral immunity to donor antigens declined over the first few 
weeks after transplantation, and the spleens of long-term recipients contained 
no ~'killer cells." Recipient lymphoid cells could mount active graft versus host 
reactions to donor strain antigens on transfer to neonatal mice. Nevertheless, 
they were distinctly less able to respond specifically by the production of killer 
cells to donor strain antigens after sensitization in vitro. No evidence that this 
defect was  associated with the  presence  of suppressor cells was forthcoming 
from several types of in vivo and in vitro tests. 
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